The present results call for a more extensive investigation of the dose-response effect of GPE on inflammation-induced depression and moreover on the ability of endogenously generated GPE to mediate part of the anti-depressant activity of IGF-I. This evidence concerns the gene IGF1 and depressive symptom measurement.